Clinical trial
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
NCT00182364 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00182364 |
|---|---|
| Title | PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) |
| Official title | PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Canadian Critical Care Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Critically Ill, Deep Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Fragmin (Dalteparin) LMWH verus Unfractionated Heparin (UFH) |
| Enrollment | 120 |
| Start date | Feb 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 17, 2006 |
| Countries | Australia, Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: